Analysis of Cost-Effectiveness of Biologic Therapies in Axial Spondyloarthritis Based on Real-World Data
Jamal Al-Saleh, Ahmed Abdelmoniem Negm, Ahlam Almarzooqi, Nasir Elamin Elhag Elsidig, Noura Zamani · 2025
Read Analysis of Cost-Effectiveness of Biologic Therapies in Axial Spondyloarthritis Based on Real-World Data by Jamal Al-Saleh, Ahmed Abdelmoniem Negm, Ahlam Almarzooqi, Nasir Elamin Elhag Elsidig, Noura Zamani (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12714858.txt.
Description
Jamal Al-Saleh and four co-authors weigh the cost worth of biologic drugs for a stiff spine illness using real world data from Dubai. More than two hundred patients were tracked for two years, with costs and life quality tallied. A life long model adds a guess at long term value.
Biologic care cost far more, driven by drug price, which took most of the spend. Value per healthy year sat high but still in a range the authors call worth it, most for patients off target. Early illness and some added traits raised the ratio. Cheaper copies could lift value further.
Catalog record
| CREATOR | Jamal Al-Saleh, Ahmed Abdelmoniem Negm, Ahlam Almarzooqi, Nasir Elamin Elhag Elsidig, Noura Zamani |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |